Efficacy of intra-articular injection for end stage hip osteoarthritis: can pain and disability be relieved?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN86638547

Enrollment

160

Registered

2006-02-10

Start date

2005-08-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip osteoarthritis Musculoskeletal Diseases Hip osteoarthritis

Interventions

The study is a prospective, randomised, blind, controlled (three arm) trial, with a further randomised standard care arm. The four groups are: 1. Standard care (no injection) 2. Standard care and inj

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age >/=50 years 2. Primary hip osteoarthritis 3. Listed for Total Hip Replacement (THR)

Exclusion criteria

Exclusion criteria: 1. Secondary hip OA 2. Collapse of femoral head on anteroposterior pelvic radiograph 3. Listed for bilateral THR 4. Co-morbid conditions resulting in gross lower limb asymmetry (e.g. stroke, amputees, severe leg shortening) 5. Inability to communicate in verbal or written English

Design outcomes

Primary

Measure	Time frame
1. Visual Analogue Scale (VAS) for global pain 2. Pain and function scales of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 3. Numact (objective activity monitor)	—

Secondary

Measure	Time frame
1. Euroqol EQ-5D 2. Outcome Measures in Rheumatoid Arthritis Clinical Trials-Osteoarthritis Research Society International (OMERACT-OARSI)	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026